Skip to content
Opiant_logo Opiant Pharmaceuticals
Main Menu
  • Contact
  • Careers
  • About
    • Corporate Overview
    • Management Team
    • Board of Directors
    • Medical Advisory Board
    • Media
    • Careers
  • Science & Technology
    • The Science of Addiction
    • Opioid Antagonists
    • Nasal Spray Delivery Technology
    • Intellectual Property
    • Publications
  • Addiction Disorders
    • Opioid Use Disorder
    • Alcohol Use Disorder
    • Acute Cannabinoid Overdose
  • Products & Pipeline
    • Pipeline Chart
    • Reversing Opioid Overdose
    • Treating Alcohol Use Disorder
    • Treating Opioid Use Disorder
    • Reversing Acute Cannabinoid Overdose
  • Patients & Families
  • Investors
    • Stock Information
      • Stock Quote & Chart
      • Historical Price Lookup
      • Investment Calculator
      • Analyst Coverage
    • News Releases
    • Events & Presentations
    • Corporate Governance
      • Board of Directors
      • Board Committees
      • Governance Documents
    • Financial & Filings
      • SEC Filings
      • Annual Reports & Proxy Statements

Medical Advisory Board

David Nutt Read Bio
David Nutt DM, FRCP, FRCPsych, FMedSci, DLaws
Hannu Alho, MD Read Bio
Hannu Alho, MD
Marc Potenza Read Bio
Marc Potenza, MD, PhD
Sandra Comer, PhD headshot Read Bio
Sandra Comer, PhD
Sharon Walsh Read Bio
Sharon Walsh, PhD
Stephanie O’Malley, PhD Read Bio
Stephanie O’Malley, PhD
Thomas R. Kosten, MD Read Bio
Thomas R. Kosten, MD
Wim van den Brink, MD, PhD Read Bio
Wim van den Brink, MD, PhD
  • Twitter
  • LinkedIn
  • Disclaimer
  • Privacy Policy
  • Terms of Use
  • Site Map
© Opiant Pharmaceuticals, 2019. All Rights Reserved.